For subjects with a diabetes duration of ≤5 years, the prevalences of adequate glycemic control in the cancer survivors, non-cancer chronic disease controls, and non-cancer, non-chronic disease controls were 66.5%, 81.0%, and 68.5%, respectively: the cancer survivor and non-cancer, chronic disease control group difference was marginally significant.
← all excerpts
Comparison of diabetes management status between cancer survivors and the general population: results from a Korean population-based survey.
1
—
—